Prostate Cancer Channel

 Videos                                                                                                                                                                 

Hear the latest prostate cancer perspective straight from the experts

 

A Patient’s Strength

As more elderly patients are living with prostate cancer, one of the greatest challenges in treating them is their overall fitness.

Dramatic Survival Benefits

New therapies and how the medical community sequences these new therapies are having a dramatic impact on prostate cancer survival rates, says Daniel J. George, MD, director of the Prostate Urologic Cancers Program, Duke University Cancer Institute.

A Changing Landscape

Daniel J. George, MD, director of the Prostate Urologic Cancers Program, Duke University Cancer Institute, discusses several advances that could significantly improve the treatment of prostate cancer.

Connection to Other Cancers

Veda Giri, MD, director of the Jefferson Clinical Cancer Genetics Service and the Men’s Genetic Risk Clinic, Sidney Kimmel Cancer Center at Jefferson Health, sheds light on what needs greater awareness when it comes to prostate cancer.

Greater Awareness Needed

Veda Giri, MD, director of the Jefferson Clinical Cancer Genetics Service and the Men’s Genetic Risk Clinic, Sidney Kimmel Cancer Center at Jefferson Health, says more awareness, advocacy and resources are needed to support progress in the treatment of prostate cancer.

Immunotherapies ‘Still Finding Their Niche’

There are opportunities to develop new targeted therapies based on the genetics and molecular features of prostate cancer, says Daniel J. George, MD, director of the Prostate Urologic Cancers Program, Duke University Cancer Institute.

A ‘Misunderstood’ Disease

Daniel J. George, MD, director of the Prostate Urologic Cancers Program, Duke University Cancer Institute, identifies two significant misconceptions regarding prostate cancer.

Genetic Breakthroughs

Breakthroughs in genetics have helped improve our understanding of prostate cancer risk and for aggressive prostate cancer, says Veda Giri, MD, director of the Jefferson Clinical Cancer Genetics Service and the Men’s Genetic Risk Clinic, Sidney Kimmel Cancer Center at Jefferson Health.

Significance of the GEM Study

Jefferson Health’s Veda Giri, MD, shares insight into the Genetic Evaluation of Men Study.

Genetic Discoveries

What has had the most dramatic impact on prostate cancer treatment? It all comes down to recent genetic discoveries, says Jefferson Health’s Veda Giri, MD.
Loading